Skip to content
DraconiticResearch
Search Sources API
181,713 studies31 sourcesUpdated 39 min ago
Peer-reviewedCC BYEuropean respiratory review : an official journal of the European Respiratory Society

Haemoptysis in chronic pulmonary vascular disease: a narrative review.

  • Jan C Kamp1,2
  • Brandon Budhram3
  • Mitja Jevnikar4
  • Karen M Olsson1,2
  • Matti J Peperhove5
  • Lavinia Neubert2,6
  • Marius M Hoeper7,2,8
  • Marc Humbert4,8
8 affiliations
  1. 1Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.
  2. 2Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
  3. 3Division of Respirology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
  4. 4Université Paris-Saclay, Inserm UMR_S 1358 (HPPIT), Department of Respiratory and Intensive Care Medicine, Hôpital Bicêtre (AP-HP), FHU André Cournand, ERN-LUNG, Le Kremlin-Bicêtre, France.
  5. 5Institute for Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
  6. 6Institute of Pathology, Hannover Medical School, Hannover, Germany.
  7. 7Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany [email protected].
  8. 8These authors contributed equally as senior authors to the manuscript.
Read full textPDFDOICite

Abstract

Haemoptysis, the expectoration of blood from the lower airways, is a complication of several pulmonary vascular diseases (PVDs). The pathophysiology of haemoptysis in chronic PVDs is complex and varies depending on the underlying condition. Computed tomography pulmonary angiography remains the gold standard for localising the bleeding source and guiding interventional therapies. Management of haemoptysis in patients with chronic PVDs can range from oxygen supplementation to angiography-guided bronchial artery embolisation, depending on bleeding severity, anatomical features and specific features of the associated disease. Regardless of the management strategy, long-term follow-up is essential in these patients owing to the risk of recurrent bleeding. The aim of this review is to comprehensively explore the characteristics of haemoptysis in selected chronic PVDs, summarise current knowledge of the pathophysiology, and provide guidance on contemporary diagnostic and treatment strategies.

Related

  1. Anticoagulation Dilemma in a Patient With Pulmonary Embolism and Massive Haemoptysis.
    Isaac Mugwano, Faith Atim Emilly, Isaac Ssinabulya +2
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Bile acid dysregulation in pulmonary arterial hypertension: strengthening the liver-lung axis in pulmonary vascular disease
    Vishal N Rao, Kurt W Prins
    American Journal of Respiratory and Critical Care MedicinePeer-reviewedPublisher termsFull textGeneral medicinePMC
  3. A Global Initiative for Chronic Obstructive Lung Disease (GOLD) Science Committee perspective on exacerbations and cardiovascular risk in chronic obstructive pulmonary disease
    Dave Singh, Alvar Agustí, Jean Bourbeau +3
    American Journal of Respiratory and Critical Care MedicinePeer-reviewedCC BY 4.0Full text2 citedGeneral medicinePMC
  4. Non-Coding RNA Regulates Pyroptosis in Chronic Obstructive Pulmonary Disease
    Xu Du, Yuan Geng, Wen-lan Fang +1
    PhenomicsPeer-reviewedLicence not statedFull textGeneral medicinePMC
  5. Sleep Quality and Daytime Sleepiness in Patients with Chronic Obstructive Pulmonary Disease in a Tertiary Care Hospital: An Observational Study
    S. Jha, A. Suwal, B. Shah +1
    medRxivPreprintAll rights reservedFull textGeneral medicinemedRxiv

Cite

BibTeXRIS
BibTeX
@article{kamp2026haemoptysis,
  title = {{Haemoptysis in chronic pulmonary vascular disease: a narrative review.}},
  author = {Jan C Kamp and Brandon Budhram and Mitja Jevnikar and Karen M Olsson and Matti J Peperhove and Lavinia Neubert and Marius M Hoeper and Marc Humbert},
  journal = {European respiratory review : an official journal of the European Respiratory Society},
  year = {2026},
  month = oct,
  doi = {10.1183/16000617.0055-2026},
  url = {https://europepmc.org/article/MED/42906941},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Haemoptysis in chronic pulmonary vascular disease: a narrative review.
AU  - Jan C Kamp
AU  - Brandon Budhram
AU  - Mitja Jevnikar
AU  - Karen M Olsson
AU  - Matti J Peperhove
AU  - Lavinia Neubert
AU  - Marius M Hoeper
AU  - Marc Humbert
PY  - 2026
DA  - 2026/10/21
JO  - European respiratory review : an official journal of the European Respiratory Society
DO  - 10.1183/16000617.0055-2026
UR  - https://europepmc.org/article/MED/42906941
AB  - Haemoptysis, the expectoration of blood from the lower airways, is a complication of several pulmonary vascular diseases (PVDs). The pathophysiology of haemoptysis in chronic PVDs is complex and varies depending on the underlying condition. Computed tomography pulmonary angiography remains the gold standard for localising the bleeding source and guiding interventional therapies. Management of haemoptysis in patients with chronic PVDs can range from oxygen supplementation to angiography-guided bronchial artery embolisation, depending on bleeding severity, anatomical features and specific features of the associated disease. Regardless of the management strategy, long-term follow-up is essential in these patients owing to the risk of recurrent bleeding. The aim of this review is to comprehensively explore the characteristics of haemoptysis in selected chronic PVDs, summarise current knowledge of the pathophysiology, and provide guidance on contemporary diagnostic and treatment strategies.
SN  - 0905-9180
SN  - 1600-0617
ER  -